tiprankstipranks
Trending News
More News >
Werewolf Therapeutics, Inc. (HOWL)
:HOWL
US Market

Werewolf Therapeutics (HOWL) Stock Forecast & Price Target

Compare
656 Followers
See the Price Targets and Ratings of:

HOWL Analyst Ratings

Strong Buy
5Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
Based on 5 analysts giving stock ratings to
Werewolf
Therapeutics
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

HOWL Stock 12 Month Forecast

Average Price Target

$8.20
▲(481.56%Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Werewolf Therapeutics in the last 3 months. The average price target is $8.20 with a high forecast of $12.00 and a low forecast of $4.00. The average price target represents a 481.56% change from the last price of $1.41.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"$6","13":"$13","-1":"-$1","2.5":"$2.5","9.5":"$9.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":12,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$12.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":8.2,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$8.20</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":4,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$4.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,2.5,6,9.5,13],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2024","6":"Aug<br/>2024","9":"Jan<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.87,1.7261538461538461,2.5823076923076926,3.4384615384615387,4.294615384615385,5.150769230769232,6.006923076923077,6.863076923076924,7.71923076923077,8.575384615384616,9.431538461538462,10.287692307692309,11.143846153846154,{"y":12,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.87,1.4338461538461538,1.9976923076923074,2.5615384615384613,3.125384615384615,3.689230769230769,4.2530769230769225,4.816923076923076,5.38076923076923,5.944615384615384,6.508461538461538,7.0723076923076915,7.636153846153845,{"y":8.2,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.87,1.1107692307692307,1.3515384615384616,1.5923076923076924,1.833076923076923,2.0738461538461537,2.3146153846153847,2.5553846153846154,2.796153846153846,3.036923076923077,3.2776923076923077,3.5184615384615383,3.7592307692307694,{"y":4,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":4.76,"date":1706745600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.38,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.02,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":5.17,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.35,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.3,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.16,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.48,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.48,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":1.24,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.87,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.87,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$12.00Average Price Target$8.20Lowest Price Target$4.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on HOWL
TipRanks AITipRanks
Not Ranked
TipRanks
$1.5
Hold
6.38%
Upside
Reiterated
06/07/25
The overall score is primarily impacted by the company's weak financial performance and valuation. Technical analysis provides some moderate support, but the corporate events surrounding the Nasdaq deficiency notice add significant risk. While clinical progress is promising, the company's financial health remains a major concern.
Bank of America Securities Analyst forecast on HOWL
Jason ZemanskyBank of America Securities
Bank of America Securities
$10$9
Buy
538.30%
Upside
Reiterated
05/27/25
Bank of America Securities Remains a Buy on Werewolf Therapeutics (HOWL)
H.C. Wainwright Analyst forecast on HOWL
Andres Y. MaldonadoH.C. Wainwright
H.C. Wainwright
$15$10
Buy
609.22%
Upside
Reiterated
05/09/25
Werewolf Therapeutics Inc. (HOWL) PT Lowered to $10 at H.C. WainwrightH.C. Wainwright analyst Andres Maldonado lowered the price target on Werewolf Therapeutics Inc. (NASDAQ: HOWL) to $10.00 (from $15.00) while maintaining a Buy rating.
Wedbush
$8$6
Buy
325.53%
Upside
Reiterated
05/09/25
Werewolf Therapeutics price target lowered to $6 from $8 at WedbushWerewolf Therapeutics price target lowered to $6 from $8 at Wedbush
Leerink Partners Analyst forecast on HOWL
Daina GrayboschLeerink Partners
Leerink Partners
$13$12
Buy
751.06%
Upside
Reiterated
05/09/25
Strategic Expansion and Clinical Potential of Werewolf Therapeutics' PREDATOR Platform Boosts Buy Rating
Citizens JMP Analyst forecast on HOWL
Reni BenjaminCitizens JMP
Citizens JMP
$4
Buy
183.69%
Upside
Reiterated
04/21/25
Citizens JMP reiterates Market Outperform Rating on Werewolf Therapeutics Inc. (HOWL)Citizens JMP analyst Reni Benjamin reiterated a Market Outperform rating and $4.00 price target on Werewolf Therapeutics Inc. (NASDAQ: HOWL).
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on HOWL
TipRanks AITipRanks
Not Ranked
TipRanks
$1.5
Hold
6.38%
Upside
Reiterated
06/07/25
The overall score is primarily impacted by the company's weak financial performance and valuation. Technical analysis provides some moderate support, but the corporate events surrounding the Nasdaq deficiency notice add significant risk. While clinical progress is promising, the company's financial health remains a major concern.
Bank of America Securities Analyst forecast on HOWL
Jason ZemanskyBank of America Securities
Bank of America Securities
$10$9
Buy
538.30%
Upside
Reiterated
05/27/25
Bank of America Securities Remains a Buy on Werewolf Therapeutics (HOWL)
H.C. Wainwright Analyst forecast on HOWL
Andres Y. MaldonadoH.C. Wainwright
H.C. Wainwright
$15$10
Buy
609.22%
Upside
Reiterated
05/09/25
Werewolf Therapeutics Inc. (HOWL) PT Lowered to $10 at H.C. WainwrightH.C. Wainwright analyst Andres Maldonado lowered the price target on Werewolf Therapeutics Inc. (NASDAQ: HOWL) to $10.00 (from $15.00) while maintaining a Buy rating.
Wedbush
$8$6
Buy
325.53%
Upside
Reiterated
05/09/25
Werewolf Therapeutics price target lowered to $6 from $8 at WedbushWerewolf Therapeutics price target lowered to $6 from $8 at Wedbush
Leerink Partners Analyst forecast on HOWL
Daina GrayboschLeerink Partners
Leerink Partners
$13$12
Buy
751.06%
Upside
Reiterated
05/09/25
Strategic Expansion and Clinical Potential of Werewolf Therapeutics' PREDATOR Platform Boosts Buy Rating
Citizens JMP Analyst forecast on HOWL
Reni BenjaminCitizens JMP
Citizens JMP
$4
Buy
183.69%
Upside
Reiterated
04/21/25
Citizens JMP reiterates Market Outperform Rating on Werewolf Therapeutics Inc. (HOWL)Citizens JMP analyst Reni Benjamin reiterated a Market Outperform rating and $4.00 price target on Werewolf Therapeutics Inc. (NASDAQ: HOWL).
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Werewolf Therapeutics

1 Month
xxx
Success Rate
10/18 ratings generated profit
56%
Average Return
+2.16%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 55.56% of your transactions generating a profit, with an average return of +2.16% per trade.
3 Months
xxx
Success Rate
9/18 ratings generated profit
50%
Average Return
+16.92%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +16.92% per trade.
1 Year
Jason ZemanskyBank of America Securities
Success Rate
5/12 ratings generated profit
42%
Average Return
+2.95%
reiterated a buy rating 16 days ago
Copying Jason Zemansky's trades and holding each position for 1 Year would result in 41.67% of your transactions generating a profit, with an average return of +2.95% per trade.
2 Years
xxx
Success Rate
3/16 ratings generated profit
19%
Average Return
-37.06%
reiterated a xxx
rating last month
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 18.75% of your transactions generating a profit, with an average return of -37.06% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

HOWL Analyst Recommendation Trends

Rating
Nov 24
Jan 25
Mar 25
Apr 25
May 25
Strong Buy
8
8
11
8
10
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
8
8
11
8
10
In the current month, HOWL has received 10 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. HOWL average Analyst price target in the past 3 months is 8.20.
Each month's total comprises the sum of three months' worth of ratings.

HOWL Financial Forecast

HOWL Earnings Forecast

Next quarter’s earnings estimate for HOWL is -$0.47 with a range of -$0.84 to -$0.36. The previous quarter’s EPS was -$0.40. HOWL beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.05% of the time in the same period. In the last calendar year HOWL has Outperformed its overall industry.
Next quarter’s earnings estimate for HOWL is -$0.47 with a range of -$0.84 to -$0.36. The previous quarter’s EPS was -$0.40. HOWL beat its EPS estimate 25.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.05% of the time in the same period. In the last calendar year HOWL has Outperformed its overall industry.

HOWL Sales Forecast

Next quarter’s sales forecast for HOWL is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. HOWL beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 47.43% of the time in the same period. In the last calendar year HOWL has Outperformed its overall industry.
Next quarter’s sales forecast for HOWL is $0.00 with a range of $0.00 to $0.00. The previous quarter’s sales results were $0.00. HOWL beat its sales estimates 25.00% of the time in past 12 months, while its overall industry beat sales estimates 47.43% of the time in the same period. In the last calendar year HOWL has Outperformed its overall industry.

HOWL Stock Forecast FAQ

What is HOWL’s average 12-month price target, according to analysts?
Based on analyst ratings, Werewolf Therapeutics, Inc.’s 12-month average price target is 8.20.
    What is HOWL’s upside potential, based on the analysts’ average price target?
    Werewolf Therapeutics, Inc. has 481.56% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is HOWL a Buy, Sell or Hold?
          Werewolf Therapeutics, Inc. has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Werewolf Therapeutics, Inc.’s price target?
            The average price target for Werewolf Therapeutics, Inc. is 8.20. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $12.00 ,the lowest forecast is $4.00. The average price target represents 481.56% Increase from the current price of $1.41.
              What do analysts say about Werewolf Therapeutics, Inc.?
              Werewolf Therapeutics, Inc.’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
                How can I buy shares of HOWL?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis